Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03754933 |
|
Recruitment Status :
Recruiting
First Posted : November 27, 2018
Last Update Posted : August 31, 2023
|
Sponsor:
GeoVax, Inc.
Collaborators:
Stanford University
Emory University
Thomas Jefferson University
Information provided by (Responsible Party):
GeoVax, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2024 |
| Estimated Study Completion Date : | August 2025 |
Publications: